Mesenchymal Stem Cell Secretions Improve Donor Heart Function Following Ex vivo Cold Storage

Overview

Journal J Thorac Cardiovasc Surg

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2020 Sep 28

PMID 32981709

Citations 12

Authors

Meijing Wang

Liangliang Yan

Qianzhen Li

Yang Yang

Mark Turrentine

Keith March

I-Wen Wang

Affiliations

Soon will be listed here.

Abstract

Objectives: Heart transplantation is the gold standard of treatments for end-stage heart failure, but its use is limited by extreme shortage of donor organs. The time "window" between procurement and transplantation sets the stage for myocardial ischemia/reperfusion injury, which constrains the maximal storage time and lowers use of donor organs. Given mesenchymal stem cell (MSC)-derived paracrine protection, we aimed to evaluate the efficacy of MSC-conditioned medium (CM) and extracellular vesicles (EVs) when added to ex vivo preservation solution on ameliorating ischemia/reperfusion-induced myocardial damage in donor hearts.

Methods: Mouse donor hearts were stored at 0°C-4°C of <1-hour cold ischemia (<1hr-I), 6hr-I + vehicle, 6hr-I + MSC-CM, 6hr-I + MSC-EVs, and 6hr-I + MSC-CM from MSCs treated with exosome release inhibitor. The hearts were then heterotopically implanted into recipient mice. At 24 hours postsurgery, myocardial function was evaluated. Heart tissue was collected for analysis of histology, apoptotic cell death, microRNA (miR)-199a-3p expression, and myocardial cytokine production.

Results: Six-hour cold ischemia significantly impaired myocardial function, increased cell death, and reduced miR-199a-3p in implanted hearts versus <1hr-I. MSC-CM or MSC-EVs in preservation solution reversed the detrimental effects of prolong cold ischemia on donor hearts. Exosome-depleted MSC-CM partially abolished MSC secretome-mediated cardioprotection in implanted hearts. MiR-199a-3p was highly enriched in MSC-EVs. MSC-CM and MSC-EVs increased cold ischemia-downregulated miR-199a-3p in donor hearts, whereas exosome-depletion neutralized this effect.

Conclusions: MSC-CM and MSC-EVs confer improved myocardial preservation in donor hearts during prolonged cold static storage and MSC-EVs can be used for intercellular transport of miRNAs in heart transplantation.

Citing Articles

Exosomes of human adipose stem cells mitigate irradiation injury to salivary glands by inhibiting epithelial-mesenchymal transition through miR-199a-3p targeting Twist1 and regulating TGFβ1/Smad3 pathway.

Guo X, Huang Z, Wu F, Jiang W, Li Y, Wang T Theranostics. 2025; 15(5):1622-1641.

PMID: 39897544 PMC: 11780531. DOI: 10.7150/thno.102346.

Unraveling the Signaling Dynamics of Small Extracellular Vesicles in Cardiac Diseases.

Cano-Carrillo S, Castillo-Casas J, Franco D, Lozano-Velasco E Cells. 2024; 13(3.

PMID: 38334657 PMC: 10854837. DOI: 10.3390/cells13030265.

Toward transplantation tolerance with adipose tissue-derived therapeutics.

Cheng H, Anggelia M, Lin C, Wei F Front Immunol. 2023; 14:1111813.

PMID: 37187733 PMC: 10175575. DOI: 10.3389/fimmu.2023.1111813.

Zwitterionic coating assisted by dopamine with metal-phenolic networks loaded on titanium with improved biocompatibility and antibacterial property for artificial heart.

Meng L, Huang C, Liu X, Qu H, Wang Q Front Bioeng Biotechnol. 2023; 11:1167340.

PMID: 37139045 PMC: 10150318. DOI: 10.3389/fbioe.2023.1167340.

Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives.

Miceli V, Bulati M, Gallo A, Iannolo G, Busa R, Conaldi P Biomedicines. 2023; 11(3).

PMID: 36979668 PMC: 10045387. DOI: 10.3390/biomedicines11030689.

References

Chullikana A, Majumdar A, Gottipamula S, Krishnamurthy S, Kumar A, Prakash V . Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction. Cytotherapy. 2014; 17(3):250-61. DOI: 10.1016/j.jcyt.2014.10.009. View

Rodrigo S, van Ramshorst J, Hoogslag G, Boden H, Velders M, Cannegieter S . Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res. 2013; 6(5):816-25. PMC: 3790917. DOI: 10.1007/s12265-013-9507-7. View

Wang L, Gu H, Turrentine M, Wang M . Estradiol treatment promotes cardiac stem cell (CSC)-derived growth factors, thus improving CSC-mediated cardioprotection after acute ischemia/reperfusion. Surgery. 2014; 156(2):243-52. DOI: 10.1016/j.surg.2014.04.002. View

Lai R, Arslan F, Lee M, Sze N, Choo A, Chen T . Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4(3):214-22. DOI: 10.1016/j.scr.2009.12.003. View

Wang M, Crisostomo P, Herring C, Meldrum K, Meldrum D . Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2006; 291(4):R880-4. DOI: 10.1152/ajpregu.00280.2006. View

Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T . Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010; 285(23):17442-52. PMC: 2878508. DOI: 10.1074/jbc.M110.107821. View

Markel T, Wang Y, Herrmann J, Crisostomo P, Wang M, Novotny N . VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol. 2008; 295(6):H2308-14. PMC: 2614539. DOI: 10.1152/ajpheart.00565.2008. View

Huang C, Gu H, Yu Q, Manukyan M, Poynter J, Wang M . Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PLoS One. 2011; 6(12):e29246. PMC: 3240662. DOI: 10.1371/journal.pone.0029246. View

Suncion V, Ghersin E, Fishman J, Zambrano J, Karantalis V, Mandel N . Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial. Circ Res. 2014; 114(8):1292-301. PMC: 4067050. DOI: 10.1161/CIRCRESAHA.114.302854. View

10.

Johnson M, Meyer K, Haft J, Kinder D, Webber S, Dyke D . Heart transplantation in the United States, 1999-2008. Am J Transplant. 2010; 10(4 Pt 2):1035-46. DOI: 10.1111/j.1600-6143.2010.03042.x. View

11.

Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S . Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012; 492(7429):376-81. DOI: 10.1038/nature11739. View

12.

Wang M, Tsai B, Crisostomo P, Meldrum D . Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock. 2006; 25(5):454-9. DOI: 10.1097/01.shk.0000209536.68682.90. View

13.

Huang C, Gu H, Zhang W, Manukyan M, Shou W, Wang M . SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol. 2011; 301(4):H1496-505. PMC: 3197365. DOI: 10.1152/ajpheart.00365.2011. View

14.

Gnecchi M, He H, Liang O, Melo L, Morello F, Mu H . Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005; 11(4):367-8. DOI: 10.1038/nm0405-367. View

15.

Christie J, Edwards L, Kucheryavaya A, Aurora P, Dobbels F, Kirk R . The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. J Heart Lung Transplant. 2010; 29(10):1104-18. DOI: 10.1016/j.healun.2010.08.004. View

16.

Cai L, Johnstone B, Cook T, Liang Z, Traktuev D, Cornetta K . Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells. 2007; 25(12):3234-43. DOI: 10.1634/stemcells.2007-0388. View

17.

Oberhuber R, Cardini B, Kofler M, Ritschl P, Oellinger R, Aigner F . Murine cervical heart transplantation model using a modified cuff technique. J Vis Exp. 2014; (92):e50753. PMC: 4692414. DOI: 10.3791/50753. View

18.

Messer S, Large S . Resuscitating heart transplantation: the donation after circulatory determined death donor. Eur J Cardiothorac Surg. 2015; 49(1):1-4. DOI: 10.1093/ejcts/ezv357. View

19.

Baglio S, Pegtel D, Baldini N . Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol. 2012; 3:359. PMC: 3434369. DOI: 10.3389/fphys.2012.00359. View

20.

Korkmaz-Icoz S, Li S, Huttner R, Ruppert M, Radovits T, Loganathan S . Hypothermic perfusion of donor heart with a preservation solution supplemented by mesenchymal stem cells. J Heart Lung Transplant. 2019; 38(3):315-326. DOI: 10.1016/j.healun.2018.12.003. View